慢性阻塞性肺疾病中西医治疗研究进展
Progress in the Treatment of Chronic Obstructive Pulmonary Disease with Chinese and Western Medicine
摘要: 随着慢阻肺防治工作的开展，中西医结合医治的特色及优势得以逐渐凸显。尽管中医学、现代医学在慢阻肺的治疗中都有着独特的见解与方法，但如何突破传统思维，使两者更有益地结合，拓宽治疗思路，探索更多治疗方法，收获更优的疗效，仍值得更深入探究。
Abstract: With the development of the prevention and treatment of COPD, the characteristics and advantages of integrated Chinese and western medicine are gradually highlighted. Although traditional Chinese medicine and modern medicine have unique insights and methods in the treatment of COPD, how to break through traditional thinking, make a more beneficial combination of the two, broaden treat-ment ideas, explore more treatment methods, and harvest a better curative effect is still worth fur-ther exploration.
文章引用：陈文畅, 李风森. 慢性阻塞性肺疾病中西医治疗研究进展[J]. 临床医学进展, 2023, 13(3): 4431-4436. https://doi.org/10.12677/ACM.2023.133635

参考文献

[1] Zhong, N., Wang, C., Yao, W., et al. (2007) Prevalence of Chronic Obstructive Pulmonary Disease in China: A Large, Population-Based Survey. American Journal of Respiratory and Critical Care Medicine, 176, 753-760. [Google Scholar] [CrossRef] 
[2] Wang, C., Xu, J., Yang, L., et al. (2018) Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease in China (the China Pulmonary Health [CPH] Study): A National Cross-Sectional Study. The Lancet, 391, 1706-1717. [Google Scholar] [CrossRef] 
[3] 张垚, 杨继, 张春阳, 翟国超, 等. 慢性阻塞性肺疾病中医药全病程治疗方案研究进展[J]. 时珍国医国药, 2020, 31(11): 2732-2735.
[4] 张伯礼, 吴勉华. 中医内科学[M]. 第10版. 北京: 中国中医药出版社, 2012: 75-77.
[5] 许建中. 慢性阻塞性肺疾病中医诊治探讨[J]. 江苏中医药, 2006(7): 4-5.
[6] 吴建军, 张莹雪, 赵妍, 等. 伴有/不伴有合并症的慢性阻塞性肺疾病稳定期患者病位特征及其与肺功能的相关性[J]. 中华中医药杂志, 2020, 35(2): 984-988.
[7] 洪敏俐. 慢性阻塞性肺疾病稳定期证素分布、兼杂特征及愈肺宁方对慢性阻塞性肺疾病稳定期证素的影响[D]: [硕士学位论文]. 福州: 福建中医药大学, 2018.
[8] 张树昌. 广东省中医院中重度慢阻肺稳定期患者的中医肺康复现状分析[D]: [硕士学位论文]. 广州: 广州中医药大学, 2020.
[9] 李杨. COPD中医证候演变分析及稳定期中医规范化管理效果观察[D]: [硕士学位论文]. 天津: 天津中医药大学, 2021.
[10] 何琛. 基于文献对慢性阻塞性肺疾病急性加重期的中医证侯规律研究[D]: [硕士学位论文]. 沈阳: 辽宁中医药大学, 2019.
[11] 刘嘉敏, 王露, 张树娟, 等. 中医辨证治疗慢性阻塞性肺疾病合并慢性呼吸衰竭有效性和安全性的Meta分析及证型分析[J]. 中草药, 2021, 52(23): 7259-7271.
[12] 谢文英, 包永生, 王俊月, 等. 中医药防治慢性阻塞性肺疾病炎症反应相关信号通路的研究进展[J]. 中国实验方剂学杂志, 2019, 25(23): 1-8.
[13] 丁香, 胡华胜, 蔡林. 升陷汤加味联合硫酸沙丁胺醇对慢性阻塞性肺疾病急性加重期患者呼吸力学、血气分析指标及血清过氧化脂质的影响[J]. 现代中西医结合杂志, 2019, 28(26): 2922-2925.
[14] 陈振翼, 方邦江, 闫诏, 等. 宽胸理肺汤治疗慢性阻塞性肺疾病急性加重期(痰浊壅肺证)患者的临床研究[J]. 中国中医急症, 2019, 28(7): 1133-1135.
[15] 黄莉, 朱启梦. 针灸联合化痰清肺方剂治疗COPD急性期的疗效观察及对FEV_1、PaCO_2的影响[J]. 基因组学与应用生物学, 2018, 37(11): 4864-4870.
[16] 洪海都, 吴鹏, 刘城鑫, 等. 穴位贴敷治疗慢性阻塞性肺疾病的选穴规律分析[J]. 中国中医急症, 2019, 28(10): 1766-1770.
[17] Zhou, Y., Zou, Y., Li, X., et al. (2014) Lung Function and Incidence of Chronic Obstructive Pulmo-nary Disease after Improved Cooking Fuels and Kitchen Ventilation: A 9-Year Prospective Cohort Study. PLOS Medi-cine, 11, e1001621. [Google Scholar] [CrossRef] [PubMed]
[18] 李佳琳, 车春莉. PM_(2.5)附着成分在慢性阻塞性肺疾病发病中的作用[J]. 国际呼吸杂志, 2020, 40(14): 1111-1115.
[19] Wu, X., Cobbina, S.J., Mao, G., et al. (2016) A Re-view of Toxicity and Mechanisms of Individual and Mixtures of Heavy Metals in the Environment. Environmental Sci-ence and Pollution Research International, 23, 8244-8259. [Google Scholar] [CrossRef] [PubMed]
[20] Costa, C., Catania, S., De Pasquale, R., et al. (2010) Exposure of Human Skin to Benzo[a]pyrene: Role of CYP1A1 and Aryl Hydrocarbon Receptor in Oxidative Stress Generation. Tox-icology, 271, 83-86. [Google Scholar] [CrossRef] [PubMed]
[21] Ivanov, S., Palmberg, L., Venge, P., et al. (2005) Interleukin-17A mRNA and Protein Expression within Cells from the Human Bronchoalveolar Space after Exposure to Organic Dust. Respiratory Research, 6, 44. [Google Scholar] [CrossRef] [PubMed]
[22] Sakornsakolpat, P., Prokopenko, D., Lamontagne, M., et al. (2019) Genetic Landscape of Chronic Obstructive Pulmonary Disease Identifies Heterogeneous Cell-Type and Phenotype Asso-ciations. Nature Genetics, 51, 494-505.
[23] 王杰, 周向东, 李琪, 等. 系统性痰液分析技术在评估COPD病情进展中的意义[J]. 临床肺科杂志, 2019, 24(6): 974-977.
[24] Stenmark, K.R., Fagan, K.A. and Frid, M.G. (2006) Hy-poxia-Induced Pulmonary Vascular Remodeling: Cellular and Molecular Mechanisms. Circulation Research, 99, 675-691. [Google Scholar] [CrossRef] 
[25] Scharf, S.M., Iqbal, M., Keller, C., et al. (2002) Hemodynamic Characterization of Patients with Severe Emphysema. American Journal of Respiratory and Criti-cal Care Medicine, 166, 314-322. [Google Scholar] [CrossRef] [PubMed]
[26] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版) [J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205.
[27] Hohlfeld, J.M., Vogel-Claussen, J., Biller, H., et al. (2018) Effect of Lung Deflation with Indacaterol plus Glycopyrronium on Ventricular Filling in Patients with Hyperinfla-tion and COPD (CLAIM): A Double-Blind, Randomised, Crossover, Placebo-Controlled, Single-Centre Trial. The Lan-cet Respiratory Medicine, 6, 368-378. [Google Scholar] [CrossRef] 
[28] 张绍新, 郭玲凌. 糖皮质激素不同给药方式治疗慢性阻塞性肺疾病急性加重期的效果和安全性研究[J]. 中国当代医药, 2017, 24(23): 46-48+65.
[29] 李欢, 吉训恋. 糖皮质激素雾化吸入和全身应用治疗AECOPD疗效及对患者CCL19、ICAM-1水平影响[J]. 中华保健医学杂志, 2022, 24(4): 270-273.
[30] 谷玉雷, 肖莉丽, 裴辉, 等. 经鼻高流量湿化氧疗与无创正压通气治疗创伤性颈髓损伤合并急性呼吸衰竭的临床治疗对比[J]. 中华急诊医学杂志, 2019(5): 563-566.
[31] 焦亚静. 分析无创正压机械通气对急性加重期慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭患者的治疗价值[J]. 中国社区医师, 2019, 35(1): 23+25.

为你推荐